Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP217309.RAp2oI0WCUXMFKx32pLQm1h_Kfj9YMXpM-oRq3SJSDgoo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP217309.RAp2oI0WCUXMFKx32pLQm1h_Kfj9YMXpM-oRq3SJSDgoo130_assertion type Assertion NP217309.RAp2oI0WCUXMFKx32pLQm1h_Kfj9YMXpM-oRq3SJSDgoo130_head.
- NP217309.RAp2oI0WCUXMFKx32pLQm1h_Kfj9YMXpM-oRq3SJSDgoo130_assertion description "[Bisulfite genomic sequencing revealed methylation of the NAT1 gene in 25 of the control cancers (33.8%) and 23 of the resistant tumors (62.2%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP217309.RAp2oI0WCUXMFKx32pLQm1h_Kfj9YMXpM-oRq3SJSDgoo130_provenance.
- NP217309.RAp2oI0WCUXMFKx32pLQm1h_Kfj9YMXpM-oRq3SJSDgoo130_assertion evidence source_evidence_literature NP217309.RAp2oI0WCUXMFKx32pLQm1h_Kfj9YMXpM-oRq3SJSDgoo130_provenance.
- NP217309.RAp2oI0WCUXMFKx32pLQm1h_Kfj9YMXpM-oRq3SJSDgoo130_assertion SIO_000772 20628863 NP217309.RAp2oI0WCUXMFKx32pLQm1h_Kfj9YMXpM-oRq3SJSDgoo130_provenance.
- NP217309.RAp2oI0WCUXMFKx32pLQm1h_Kfj9YMXpM-oRq3SJSDgoo130_assertion wasDerivedFrom befree-20150227 NP217309.RAp2oI0WCUXMFKx32pLQm1h_Kfj9YMXpM-oRq3SJSDgoo130_provenance.
- NP217309.RAp2oI0WCUXMFKx32pLQm1h_Kfj9YMXpM-oRq3SJSDgoo130_assertion wasGeneratedBy ECO_0000203 NP217309.RAp2oI0WCUXMFKx32pLQm1h_Kfj9YMXpM-oRq3SJSDgoo130_provenance.